Cutler Group’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $8K | Sell |
188
-6
| -3% | -$255 | ﹤0.01% | 653 |
|
|
2023
Q4 | $9K | Sell |
194
-194
| -50% | -$9K | ﹤0.01% | 1005 |
|
|
2023
Q3 | $15K | Sell |
388
-45
| -10% | -$1.74K | ﹤0.01% | 949 |
|
|
2023
Q2 | $46K | Buy |
+433
| New | +$46K | 0.01% | 636 |
|
|
2023
Q1 | – | Sell |
-54
| Closed | -$18K | – | 1508 |
|
|
2022
Q4 | $18K | Sell |
54
-125
| -70% | -$41.7K | ﹤0.01% | 1117 |
|
|
2022
Q3 | $33K | Sell |
179
-69
| -28% | -$12.7K | ﹤0.01% | 1025 |
|
|
2022
Q2 | $52K | Buy |
248
+154
| +164% | +$32.3K | ﹤0.01% | 868 |
|
|
2022
Q1 | $31K | Sell |
94
-50
| -35% | -$16.5K | ﹤0.01% | 1209 |
|
|
2021
Q4 | $46K | Sell |
144
-37
| -20% | -$11.8K | ﹤0.01% | 1209 |
|
|
2021
Q3 | $88K | Sell |
181
-7
| -4% | -$3.4K | ﹤0.01% | 1004 |
|
|
2021
Q2 | $87K | Sell |
188
-15
| -7% | -$6.94K | ﹤0.01% | 1042 |
|
|
2021
Q1 | $139K | Sell |
203
-235
| -54% | -$161K | 0.01% | 788 |
|
|
2020
Q4 | $323K | Buy |
438
+185
| +73% | +$136K | 0.02% | 450 |
|
|
2020
Q3 | $175K | Sell |
253
-360
| -59% | -$249K | 0.01% | 516 |
|
|
2020
Q2 | $519K | Buy |
613
+324
| +112% | +$274K | 0.03% | 257 |
|
|
2020
Q1 | $103K | Buy |
+289
| New | +$103K | 0.01% | 588 |
|